ダーマルフィラー(皮膚充填剤)の世界市場予測

【英語タイトル】Global Facial Injectable Market Research Report- Forecast To 2021

Market Research Futureが出版した調査資料(MRF706002)・商品コード:MRF706002
・発行会社(調査会社):Market Research Future
・発行日:2016年9月1日
・ページ数:106
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(印刷不可)USD4,450 ⇒換算¥502,850見積依頼/購入/質問フォーム
Enterprisewide Price (Global Site License)USD6,250 ⇒換算¥706,250見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Introduction Facial Injectable or also known as Dermal Fillers are products which help in a trending application known as bio-engineering or facial rejuvenation. As humans age the facial skin is bound to lose subcutaneous fat naturally, the skin is lured closer to the facial working muscles hence smile lines and wrinkles over the face become more visible.
Global Facial Injectable market has been segmented on the basis of types which comprises of Hyaluronic Acid, Collagen, Botulinum Toxin, Polymers and Particles and others. On the basis of end users which consists of hospitals, clinics, research and development facilities and others. On the basis of application which consists of facial surgery, facial uplift and others.
The global market for Facial Injectable is expected to reach US$ 9043.9 million by the end of the forecasted period and is expected to grow at a CAGR of 13.2%.

Key Players
The key players profiled in the research report are Allergan Inc (Ireland), Merz Pharma (Germany), Ipsen (France), Valeant Pharmaceuticals (Canada), Galderma (Switzerland), Integra Lifesciences (US), Tei Biosciences, Fibrogen (Finland), Ethicon (US) and others.

Study Objectives:
 To provide insights about factors, influencing and affecting the market growth.
 To provide historically and forecast revenue of the market segments and sub-segments with respect to regional markets and their countries.
 To provide historical and forecast revenue of the market segments based on types, application, end user and others.
 To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market.

Target Audience
• Facial Injectable manufacturers
• Facial Injectable Suppliers
• Pharmaceutical companies
• Research and Development (R&D) Companies
• Medical Research Laboratories
• Academic Medical Institutes and Universities

Key Findings
• The global Facial Injectable market and is expected to reach USD 9043.9 million by 2021.
• Regionally, North America holds the largest market share of global Facial Injectable market and is expected to reach USD 3428.2 million by 2021.
• Asia Pacific market is expected to be the fastest growing market, and expected to grow at a CAGR of 13.6% from 2016 to 2021

The reports also cover country level analysis:
America
• North America
Europe
Western Europe
• Germany
• France
• Italy
• Spain
• UK
• Rest of Western Europe
• Eastern Europe
Asia
• China
• India
• Japan
• South Korea
• Rest of Asia
Middle East & Africa

【レポートの目次】

TABLE OF CONTENTS

1 MARKET OVERVIEW 12
1.1 PRODUCT OVERVIEW AND SCOPE OF FACIAL INJECTABLE 12
1.2 SPECIFICATIONS OF FACIAL INJECTABLE 13
1.2.1 HYALURONIC ACID 13
1.2.2 COLLAGEN 13
1.2.3 BOTULINUM TOXIN 13
1.2.4 POLYMERS AND PARTICLES 14
2 RESEARCH METHODOLGY 17
2.1 PRIMARY RESEARCH: 18
2.2 SECONDARY RESEARCH: 18
3 MARKET DYNAMICS 19
3.1 DRIVERS 19
3.1.1 GROWING DEMAND FOR FACIAL AESTHETIC TREATMENTS 19
3.1.2 TECHNOLOGICAL ADVANCEMENTS 19
3.1.3 EFFECTS OF POLLUTION 19
3.1.4 INCREASING ACCEPTANCE OF SOFT TISSUE FILLERS 20
3.1.5 GROWING DEMAND FOR DERMAL FILLER TECHNIQUES FROM ASIAN REGION 20
3.2 RESTRAINTS: 20
3.2.1 COMPLICATION DURING SURGERY 20
3.2.2 SIDE EFFECTS ASSOCIATED WITH FACIAL INJECTABLE 21
3.3 OPPORTUNITY 21
3.3.1 RISING AWARENESS ABOUT COMBINATION THERAPIES 21
3.4 PORTERS FIVE FORCES 22
3.5 BARGAINING POWER OF SUPPLIERS 23
3.6 BARGAINING POWER OF BUYERS 23
3.7 THREAT OF NEW ENTRANTS 23
3.8 THREAT OF SUBSTITUTES 23
3.9 INTENSITY OF RIVALRY 23
3.10 VALUE CHAIN ANALYSIS 24
3.10.1 INPUTS 24
3.10.2 DRUG DEVELOPMENT 24
3.10.3 MANUFACTURING PROCESS OF FACIAL INJECTABLE 24
3.10.4 MARKETING AND DISTRIBUTION 25
3.11 SUPPLY CHAIN 25
4 GLOBAL FACIAL INJECTABLE MARKET BY REGIONS 27
4.1 GLOBAL FACIAL INJECTABLE MARKET 27
4.2 NORTH AMERICA FACIAL INJECTABLE MARKET 29
4.3 NORTH AMERICA FACIAL INJECTABLE MARKET, BY TYPE 32
4.4 NORTH AMERICA FACIAL INJECTABLE MARKET, BY APPLICATION 35
4.5 NORTH AMERICA FACIAL INJECTABLE MARKET, BY COUNTRY: PRICE ($) 36
4.5.1 BOTULINUM TOXIN PRICE: BY COUNTRY ($) 36
4.5.2 HYALURONIC ACID PRICE: BY COUNTRY ($) 36
4.5.3 POLYMERS AND PARTICLES PRICE: BY COUNTRY ($) 37
4.5.4 COLLAGEN PRICE: BY COUNTRY ($) 37
4.6 NORTH AMERICA NUBER OF FACIAL INJECTABLE PROCEDURES BY COUNTRY, 2013-2021 38
4.6.1 BOTULINUM TOXIN 38
4.6.2 HYALURONIC ACID 38
4.6.3 POLYMERS & PARTICLES 38
4.6.4 COLLAGEN 39
4.7 US FACIAL INJECTABLE MARKET 40
4.7.1 U.S FACIAL INJECTABLE MARKET BY TYPE 40
4.7.2 U.S FACIAL INJECTABLE MARKET BY APPLICATIONU.S. FACIAL INJECTABLE MARKET, BY APPLICATION (USD MILLION) 41
4.7.3 U.S FACIAL INJECTABLE MARKET BYTYPE: PRICE ($) 42
4.8 CANADA FACIAL INJECTABLE MARKET 42
4.8.1 CANADA FACIAL INJECTABLE MARKET BY TYPE 42
4.8.2 CANADA FACIAL INJECTABLE MARKET BY APPLICATION 44
4.8.3 CANADA FACIAL INJECTABLE MARKET BY TYPE: PRICE ($) 45
4.9 EUROPE FACIAL INJECTABLE MARKET 45
4.9.1 EUROPE FACIAL INJECTABLE MARKET, BY TYPE 45
4.9.2 EUROPE FACIAL INJECTABLE MARKET, BY APPLICATION 48
4.9.3 EUROPE FACIAL INJECTABLE MARKET, BY TYPE: PRICE ($) 50
4.10 EUROPE FACIAL INJECTABLE MARKET, BY COUNTRY (USD MILLION) 50
4.10.1 RUSSIA FACIAL INJECTABLE MARKET 50
4.10.2 GERMANY FACIAL INJECTABLE MARKET 51
4.10.3 FRANCE FACIAL INJECTABLE MARKET 51
4.10.4 U.K. FACIAL INJECTABLE MARKET 52
4.10.5 ITALY FACIAL INJECTABLE MARKET 52
4.10.6 SPAIN FACIAL INJECTABLE MARKET 53
4.10.7 REST OF EUROPE FACIAL INJECTABLE MARKET 53
4.11 EUROPE FACIAL INJECTABLE MARKET TYPES BY COUNTRY (VOLUME) 54
4.11.1 EUROPE HYALURONIC ACID 54
4.11.2 EUROPE BOTULINUM TOXIN 54
4.12 EUROPE FACIAL INJECTABLE MARKET BY APPLICATION (USD MILLION) 55
4.12.1 RUSSIA FACIAL INJECTABLE MARKET 55
4.12.2 GERMANY FACIAL INJECTABLE MARKET 55
4.12.3 FRANCE FACIAL INJECTABLE MARKET 55
4.12.4 U.K. FACIAL INJECTABLE MARKET 56
4.12.5 ITALY FACIAL INJECTABLE MARKET 56
4.12.6 SPAIN FACIAL INJECTABLE MARKET 56
4.12.7 REST OF EUROPE FACIAL INJECTABLE MARKET 57
4.13 ASIA FACIAL INJECTABLE MARKET 57
4.14 ASIA FACIAL INJECTABLE MARKET, BY TYPE 60
4.14.1 ASIA BOTULINUM TOXIN MARKET, BY COUNTRY 60
4.14.2 ASIA HYALURONIC ACID MARKET, BY COUNTRY 61
4.14.3 ASIA POLYMERS & PARTICLES MARKET, BY COUNTRY 62
4.14.4 ASIA COLLAGEN MARKET, BY COUNTRY 63
4.15 ASIA FACIAL INJECTABLE MARKET, BY APPLICATION 63
4.16 ASIA FACIAL INJECTABLE MARKET,BY TYPE: PRICE ($) 65
4.17 ASIA FACIAL INJECTABLE PROCEDURE: BY COUNTRY 66
4.17.1 SOUTH KOREA FACIAL INJECTABLE MARKET 68
4.17.2 JAPAN FACIAL INJECTABLE MARKET 69
4.17.3 CHINA FACIAL INJECTABLE MARKET 71
4.17.4 INDIA FACIAL INJECTABLE MARKET 72
4.17.5 REST OF ASIA FACIAL INJECTABLE MARKET 73
5 COMPETITIVE LANDSCAPE 75
5.1 GLOBAL FACIAL INJECTABLE MARKET COMPETITION BY MANUFACTURERS 75
5.1.1 GLOBAL FACIAL INJECTABLE SALES AND MARKET SHARE OF KEY MANUFACTURERS (2015 AND 2016) 75
5.2 GLOBAL FACIAL INJECTABLE MARKET: COMPANY SHARE ANALYSIS, 2015 (%) 76
6 GLOBAL FACIAL INJECTABLE MARKET: COMPANY PROFILE 77
6.1 GALDERMA 77
6.1.1 COMPANY OVERVIEW 78
6.1.2 PRODUCT OVERVIEW 78
6.1.3 FINANCIALOVERVIEW 78
6.1.4 MANUFACTURING UNITS. 79
6.2 ALLERGAN 81
6.2.1 COMPANY OVERVIEW 81
6.2.2 PRODUCT OVERVIEW 82
6.2.4 KEY DEVELOPMENTS 83
6.3 MERZ PHARMA 84
6.3.1 COMPANY OVERVIEW 85
6.3.2 PRODUCT OVERVIEW 85
6.3.3 FINANCIAL OVERVIEW 86
6.3.4 KEY DEVLOPMENTS 87
6.3.5 MANUFACTURING UNITS 87
6.4 VALEANT PHARMACEUTICALS 88
6.4.1 COMPANY OVERVIEW 89
6.4.2 PRODUCT OVERVIEW 89
6.4.3 FINANCIAL OVERVIEW 90
6.4.4 KEY DEVELOPMENTS 90
6.4.5 MANUFACTURING UNITS 91
6.5 INTEGRA LIFESCIENCES 94
6.5.1 COMPANY OVERVIEW 94
6.5.2 PRODUCT OVERVIEW 94
6.5.4 KEY DEVELOPMENTS 95
6.5.5 MANUFACTURING UNITS 96
6.6 SANOFI 97
6.6.1 COMPANY OVERVIEW 97
6.6.2 PRODUCT OVERVIEW 97
6.6.3 FINANCIAL OVERVIEW 98
6.6.4 KEY DEVELOPMENTS 98
6.7 SINCLAIR 99
6.7.1 COMPANY OVERVIEW 99
6.7.2 PRODUCT OVERVIEW 99
6.7.3 FINANCIAL OVERVIEW: 100
6.7.4 KEY DEVELOPMENTS 100
6.8 SUNEVA MEDICAL 101
6.8.1 COMPANY OVERVIEW 101
6.8.2 PRODUCT OVERVIEW 101
6.8.3 FINANCIAL OVERVIEW 101
6.9 SCIVISION BIOTECH INC. 102
6.9.1 COMPANY OVERVIEW 102
6.9.2 PRODUCT OVERVIEW 102
6.9.3 FINANCIAL OVERVIEW 102
7 FACIAL INJECTABLE MARKET: TECHNOLOGY AND DEVELOPMENT TREND 103
8 CONCLUSION 105

LIST OF TABLES

TABLE 1 APPLICATIONS OF FACIAL INJECTABLE 12
TABLE 2 GLOBAL FACIAL INJECTABLE MARKET: MARKET STRUCTURE 16
TABLE 4 GLOBAL FACIAL INJECTABLE MARKET SHARE, BY REGION 2015 (%) 27
TABLE 5 GLOBAL FACIAL INJECTABLE MARKET SHARE, 2013-2021 (%) 28
TABLE 6 GLOBAL FACIAL INJECTABLE MARKET: IMPORT EXPORT DATA 2015 (TONS) 28
TABLE 7 NORTH AMERICA FACIAL INJECTABLE MARKET, BY COUNTRY (USD MILLION) 29
TABLE 8 NORTH AMERICA FACIAL INJECTABLE MARKET, BY COUNTRY (VOLUME) 30
TABLE 9 NORTH AMERICA FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 30
TABLE 10 NORTH AMERICA FACIAL INJECTABLE MARKET, BY TYPE (VOLUME) 31
TABLE 11 NORTH AMERICA FACIAL INJECTABLE MARKET, BY APPLICATION (USD MILLION) 31
TABLE 12 NORTH AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY (USD MILLION) 32
TABLE 13 NORTH AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY (VOLUME) 33
TABLE 14 NORTH AMERICA HYALURONIC ACID MARKET, BY COUNTRY (USD MILLION) 33
TABLE 15 NORTH AMERICA HYALURONIC ACID MARKET, BY COUNTRY (VOLUME) 33
TABLE 16 NORTH AMERICA POLYMERS & PARTICLES MARKET, BY COUNTRY
(USD MILLION) 33
TABLE 17 NORTH AMERICA CALCIUM HYDROXYLAPATITE MARKET, BY COUNTRY
(VOLUME) 34
TABLE 18 NORTH AMERICA POLY-L-LACTIC ACID MARKET, BY COUNTRY (VOLUME) 34
TABLE 19 NORTH AMERICA POLYMETHYLMETHACRYLATE MARKET, BY COUNTRY
(VOLUME) 34
TABLE 20 NORTH AMERICA COLLAGEN MARKET, BY COUNTRY (USD MILLION) 34
TABLE 21 NORTH AMERICA COLLAGEN MARKET, BY COUNTRY (VOLUME) 35
TABLE 22 NORTH AMERICA FACIAL LINE CORRECTION TREATMENT MARKET, BY
COUNTRY (USD MILLION) 35
TABLE 23 NORTH AMERICA FACE-LIFT MARKET, BY COUNTRY (USD MILLION) 35
TABLE 24 NORTH AMERICA LIP TREATMENTS MARKET, BY COUNTRY (USD MILLION) 36
TABLE 25 NORTH AMERICA BOTULINUM TOXIN PRICE: BY COUNTRY : PRICE ($) 36
TABLE 26 NORTH AMERICA HYALURONIC ACIDPRICE: BY COUNTRY ($) 36
TABLE 27 NORTH AMERICA CALCIUM HYDROXYLAPATITE PRICE: BY COUNTRY ($) 37
TABLE 28 NORTH AMERICA POLY-L-LACTIC ACID PRICE: BY COUNTRY ($) 37
TABLE 29 NORTH AMERICA POLYMETHLMETHACRYLATE PRICE BY: COUNTRY ($) 37
TABLE 30 NORTH AMERICA COLLAGEN PRICE: BY COUNTRY ($) 37
TABLE 31 BOTULINUM TOXIN NUMBER OF FACIAL INJECTABLE PROCEDURES USING0
BOTULINUM TOXIN, 2013-2021 38
TABLE 32 NUMBER OF FACIL INJECTABLE PROCEDURES USING HYALURONIC ACID
2013-2021 38
TABLE 33 NUMBER OF FACIL INJECTABLE PROCEDURES USING CALCIUM
HYDROXYLAPATITE 2013-2021 38
TABLE 34 NUMBER OF FACIL INJECTABLE PROCEDURES USING POLY-L-LACTIC ACID
2013-2021 39
TABLE 35 NUMBER OF FACIL INJECTABLE PROCEDURES USING
POLYMETHYLMETHACRYLATE 2013-2021 39
TABLE 36 NUMBER OF FACIL INJECTABLE PROCEDURES USING COLLAGEN
(NON-SURGICAL FACE-LIFT PROCEDURES) (2013-2021) 39
TABLE 37 U.S. FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 40
TABLE 38 U.S. FACIAL INJECTABLE MARKET, BY TYPE (VOLUME) 41
TABLE 39 U.S. FACIAL INJECTABLE MARKET, BY TYPE: PRICE ($) 42
TABLE 40 CANADA FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 42
TABLE 41 CANADA FACIAL INJECTABLE MARKET, BY TYPE (VOLUME) 43
TABLE 42 CANADA FACIAL INJECTABLE MARKET, BY APPLICATION (USD MILLION) 44
TABLE 43 CANADA FACIAL INJECTABLE MARKET, BY TYPE: PRICE ($) 45
TABLE 44 EUROPE FACIAL INJECTABLE MARKET, BY COUNTRY (USD MILLION) 45
TABLE 45 EUROPE FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 47
TABLE 46 EUROPE FACIAL INJECTABLE MARKET, BY TYPE (VOLUME) 48
TABLE 47 EUROPE FACIAL INJECTABLE MARKET, BY APPLICATION (USD MILLION) 48
TABLE 48 RUSSIA FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 50
TABLE 49 GERMANY FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 51
TABLE 50 FRANCE FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 51
TABLE 51 U.K. FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 52
TABLE 52 ITALY FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 52
TABLE 53 SPAIN FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 53
TABLE 54 REST OF EUROPE FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 53
TABLE 55 EUROPE HYALURONIC ACID MARKET, BY COUNTRY (VOLUME) 54
TABLE 56 EUROPE BOTULINUM TOXIN MARKET, BY COUNTRY (VOLUME) 54
TABLE 57 RUSSIA FACIAL INJECTABLE MARKET BY APPLICATION (USD MILLION) 55
TABLE 58 GERMANY FACIAL INJECTABLE MARKET BY APPLICATION (USD MILLION) 55
TABLE 59 FRANCE FACIAL INJECTABLE MARKET BY APPLICATION (USD MILLION) 55
TABLE 60 U.K FACIAL INJECTABLE MARKET, BY APPLICATION (USD MILLION) 56
TABLE 61 ITALY FACIAL INJECTABLE MARKET, BY APPLICATION (USD MILLION) 56
TABLE 62 SPAIN FACIAL INJECTABLE MARKET, BY APPLICATION (USD MILLION) 56
TABLE 63 REST OF EUROPE FACIAL INJECTABLE MARKET, BY APPLICATION
(USD MILLION) 57
TABLE 64 ASIA FACIAL INJECTABLE MARKET, BY COUNTRY (USD MILLION) 57
TABLE 65 ASIA FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 58
TABLE 66 ASIA FACIAL INJECTABLE MARKET, BY TYPE ( VOLUME) 59
TABLE 67 ASIA FACIAL INJECTABLE MARKET, BY APPLICATION (USD MILLION) 59
TABLE 68 ASIA BOTULINUM TOXIN MARKET, BY COUNTRY (USD MILLION) 60
TABLE 69 ASIA BOTULINUM TOXIN MARKET, BY COUNTRY (VOLUME) 61
TABLE 70 ASIA HYALURONIC ACID MARKET, BY COUNTRY USD MILLION 61
TABLE 71 ASIA HYALURONIC ACID MARKET, BY COUNTRY (VOLUME) 61
TABLE 72 ASIA POLYMERS & PARTICLES MARKET, BY COUNTRY (USD MILLION) 62
TABLE 74 ASIA POLY-L-LACTIC ACID MARKET, BY COUNTRY (VOLUME) 62
TABLE 75 ASIA POLYMETHYLMETHACRYLATE MARKET, BY COUNTRY (VOLUME) 63
TABLE 76 ASIA COLLAGEN MARKET, BY COUNTRY (USD MILLION) 63
TABLE 77 ASIA FACIAL LINE CORRECTION TREATMENT MARKET, BY COUNTRY
(USD MILLION) 63
TABLE 78 ASIA FACE-LIFT MARKET, BY COUNTRY (USD MILLION) 64
TABLE 79 ASIA LIP TREATMENTS MARKET, BY COUNTRY (USD MILLION) 64
TABLE 80 ASIA BOTULINUM TOXIN PRICE: BY COUNTRY ($) 65
TABLE 81 ASIA HYALURONIC ACID PRICE: BY COUNTRY ($) 65
TABLE 82 ASIA CALCIUM HYDROXYLAPATITE PRICE: BY COUNTRY ($) 65
TABLE 83 ASIA POLY-L-LACTIC ACID PRICE: BY COUNTRY ($) 66
TABLE 84 ASIA POLYMETHYLMETHACRYLATE PRICE: BY COUNTRY ($) 66
TABLE 85 NUMBER OF FACIL INJECTABLE PROCEDURES USING BOTULINUM TOXIN 66
TABLE 86 NUMBER OF FACIL INJECTABLE PROCEDURES USING HYALURONIC ACID 67
TABLE 87 NUMBER OF FACIL INJECTABLE PROCEDURES USING CALCIUM HYDROXYLAPATITE 67
TABLE 88 NUMBER OF FACIL INJECTABLE PROCEDURES USING POLY-L-LACTIC ACID 67
TABLE 89 NUMBER OF FACIL INJECTABLE PROCEDURES USING
POLYMETHYLMETHACRYLATE 68
TABLE 90 SOUTH KOREA FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 68
TABLE 91 SOUTH KOREA FACIAL INJECTABLE MARKET, BY APPLICATION (USD MILLION) 68
TABLE 92 SOUTH KOREA FACIAL INJECTABLE MARKET BY TYPE (VOLUME) 69
TABLE 93 SOUTH KOREA FACIAL INJECTABLE BY TYPE: PRICE ($) 69
TABLE 94 JAPAN FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 69
TABLE 95 JAPAN FACIAL INJECTABLE MARKET, BY APPLICATION (USD MILLION) 70
TABLE 96 JAPAN FACIAL INJECTABLE MARKET BY TYPE (VOLUME) 70
TABLE 97 JAPAN FACIAL INJECTABLE BY TYPE: PRICE ($) 70
TABLE 98 CHINA FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 71
TABLE 99 CHINA FACIAL INJECTABLE MARKET, BY APPLICATION (USD MILLION) 71
TABLE 100 CHINA FACIAL INJECTABLE MARKET BY TYPE (VOLUME) 71
TABLE 101 CHINA FACIAL INJECTABLE BY TYPE: PRICE ($) 72
TABLE 102 INDIA FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 72
TABLE 103 INDIA FACIAL INJECTABLE MARKET, BY APPLICATION (USD MILLION) 72
TABLE 104 INDIA FACIAL INJECTABLE MARKET BY TYPE (VOLUME) 73
TABLE 105 INDIA FACIAL INJECTABLE BY TYPE: PRICE ($) 73
TABLE 106 REST OF ASIA FACIAL INJECTABLE MARKET, BY TYPE (USD MILLION) 73
TABLE 107 REST OF ASIA FACIAL INJECTABLE MARKET, BY APPLICATION (USD MILLION) 74
TABLE 108 GLOBAL FACIAL INJECTABLE SALES OF KEY MANUFACTURERS (2015 AND 2016) 75
TABLE 109 GLOBAL FACIAL INJECTABLE SALES BY MANUFACTURERS (2015 & 2016) 75
TABLE 110 GLOBAL FACIAL INJECTABLE MARKET: COMPANY SHARE ANALYSIS, 2015 (%) 76
TABLE 111 GALDERMA BASIC INFORMATION LIST 78
TABLE 112 ALLERGAN BASIC INFORMATION LIST 81
TABLE 113 MERZ BASIC INFORMATION LIST 85
TABLE 114 VALEANT PHARMACEUTICALS BASIC INFORMATION LIST 89
TABLE 115 INTEGRA LIFESCIENCES BASIC INFORMATION LIST 94
TABLE 116 SANOFI BASIC INFORMATION LIST 97
TABLE 117 SINCLAIR BASIC INFORMATION LIST 99
TABLE 118 SUNEVA MEDICAL BASIC INFORMATION LIST 101
TABLE 119 SCIVISION BASIC INFORMATION LIST 102


LIST OF FIGURES

FIGURE 1 PICTURE OF FACIAL INJECTABLE APPLICATION 15
FIGURE 2 RESEARCH PROCESS 17
FIGURE 3 PORTERS FIVE FORCES MODEL 22
FIGURE 4 NORTH AMERICA FACIAL INJECTABLE MARKET, BY COUNTRY (USD MILLION) 29
FIGURE 5 NORTH AMERICA FACIAL INJECTABLE MARKET SHARE, BY TYPE, 2015 (%) 30
FIGURE 6 NORTH AMERICA FACIAL INJECTABLE MARKET SHARE, BY APPLICATION 2015
(%) 32
FIGURE 7 US FACIAL INJECTABLE MARKET SHARE, BY TYPES, 2015 (%) 40
FIGURE 8 US FACIAL INJECTABLE MARKET SHARE, BY APPLICATION 2015 (%) 41
FIGURE 9 CANADA MARKET SHARE OF FACIAL INJECTABLE BY TYPES IN 2015 (%) 43
FIGURE 10 CANADA FACIAL INJECTABLE MARKET SHARE, BY APPLICATION 2015 (%) 44
FIGURE 11 EUROPE FACIAL INJECTABLE MARKET SHARE, BY COUNTRY 2015, (%) 46
FIGURE 12 REVENUE OF FACIAL INJECTABLE BY REGIONS (2013-2021) 46
FIGURE 13 EUROPE FACIAL INJECTABLE REVENUE GROWTH RATE BY REGIONS (2015 & 2021) (%) 47
FIGURE 14 EUROPE FACIAL INJECTABLE MARKET SHARE, BY TYPE 2015 (%) 48
FIGURE 15 EUROPE FACIAL INJECTABLE MARKET SHARE, BY APPLICATION 2015 (%) 49
FIGURE 16 EUROPE FACIAL INJECTABLE SALES GROWTH RATE BY APPLICATION (2013-2021) 49
FIGURE 17 EUROPE FACIAL INJECTABLE MARKET, BY TYPE: PRICE ($) 50
FIGURE 18 ASIA FACIAL INJECTABLE MARKET SHARE, BY COUNTRY 2015 (%) 58
FIGURE 19 ASIA FACIAL INJECTABLE MARKET SHARE, BY TYPE 2015 (%) 59
FIGURE 20 ASIA FACIAL INJECTABLE MARKET SHARE, BY APPLICATION 2015 (%) 60
FIGURE 21 GLOBAL FACIAL INJECTABLE MARKET: COMPANY SHARE ANALYSIS, 2015 (%) 76
FIGURE 22 PRODUCT PICTURE 77
FIGURE 23 PRODUCT PICTURE 84
FIGURE 24 PRODUCT PICTURE 88


【レポートのキーワード】

ダーマルフィラー、皮膚充填剤

★調査レポート[ダーマルフィラー(皮膚充填剤)の世界市場予測] (コード:MRF706002)販売に関する免責事項を必ずご確認ください。
★調査レポート[ダーマルフィラー(皮膚充填剤)の世界市場予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆